Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

about

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

P2860

Q55348052-6847BE2F-E1CE-4D20-A18E-6E7980485B04

P2860

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

Item

http://www.wikidata.org/entity/Q55257766

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

@en

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

@nl

type

Item

label

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

@en

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

@nl

prefLabel

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

@en

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

@nl

P1476

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

@en

P2093

Andrew S Luksik

http://www.w3.org/2001/XMLSchema#string

Betty Tyler

http://www.w3.org/2001/XMLSchema#string

Christopher M Jackson

http://www.w3.org/2001/XMLSchema#string

Debebe Theodros

http://www.w3.org/2001/XMLSchema#string

Drew M Pardoll

http://www.w3.org/2001/XMLSchema#string

Eileen Kim

http://www.w3.org/2001/XMLSchema#string

Henry Brem

http://www.w3.org/2001/XMLSchema#string

Michael Lim

http://www.w3.org/2001/XMLSchema#string

Russell Maxwell

http://www.w3.org/2001/XMLSchema#string

Tomas Garzon-Muvdi

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset

Structural and functional features of central nervous system lymphatic vessels.

The blockade of immune checkpoints in cancer immunotherapy

Prospects of immune checkpoint modulators in the treatment of glioblastoma

Immune checkpoint blockade: a common denominator approach to cancer therapy

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

P304

20681-20697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25061

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sudipto Ganguly

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29755681

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5945499

http://www.w3.org/2001/XMLSchema#string

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

about

P2860

P2860

Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932